Monoclonal antibodies against SARS-CoV-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monoclonal antibodies against SARS-CoV-2, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2